Circadian changes in CSF dopaminergic measures in restless legs syndrome

被引:64
作者
Earley, Christopher J.
Hyland, Keith
Allen, Richard P.
机构
[1] Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Dept Neurol, Baltimore, MD 21224 USA
[2] Horizon Mol Med, Dept Neurochem, Atlanta, GA USA
关键词
dopaminergic; biopterin; 3-ortho-methyldopa; cerebrospinal fluid; restless legs syndrome; circadian;
D O I
10.1016/j.sleep.2005.09.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: Restless legs syndrome (RLS) has a circadian component with symptoms being prominent at night. The dopaminergic (DAergic) system, which plays a role in RLS, entails circadian changes that parallel RLS symptom changes. The aim of this study was to look for relative and diurnal differences in DAergic activity. Patients and methods: All RLS subjects were treated prior to their enrollment in the study but were all drug-free for at least 2 weeks prior to evaluation. Cerebrospinal fluid (CSF) collected at 10 p.m. was used to determine DA-related co-factors and metabolites. These were compared to CSF values collected in a previous study at 10 a.m. Results: The only significant finding from the 10 p.m. samples (30 RLS; 22 control) was increased 3-ortho-methyldopa (3OMD) for RLS compared to controls. A comparison of the 10 p.m. to 10 a.m. values (16 RLS; 9 controls) showed small, non-significant diurnal changes for controls but large diurnal changes in tetrahydrobiopterin (BH4), HVA:5HIAA ratio and 3OMD for RLS, with the 10 a.m. sample showing increases in all three CSF factors compared to the 10 p.m. sample. Conclusions: The greater diurnal changes in RLS suggest greater fluctuations than normal in DAergic circadian dynamics. The increased 3OMD concentration in the absence of concurrent exogenous levodopa (L-dopa) suggests changes in synthesis or metabolism Of L-dopa in RLS. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:263 / 268
页数:6
相关论文
共 38 条
[1]   INTERACTING NEUROTRANSMITTER SYSTEMS - A NONEXPERIMENTAL APPROACH TO THE 5HIAA-HVA CORRELATION IN HUMAN CSF [J].
AGREN, H ;
MEFFORD, IN ;
RUDORFER, MV ;
LINNOILA, M ;
POTTER, WZ .
JOURNAL OF PSYCHIATRIC RESEARCH, 1986, 20 (03) :175-193
[2]   Family history study of the restless legs syndrome [J].
Allen, R. P. ;
La Buda, M. C. ;
Becker, P. ;
Earley, C. J. .
SLEEP MEDICINE, 2002, 3 :S3-S7
[3]   Defining the phenotype of the restless legs syndrome (RLS) using age-of-symptom-onset [J].
Allen, Richard P. ;
Earley, Christopher J. .
SLEEP MEDICINE, 2000, 1 (01) :11-19
[4]   Validation of the Johns Hopkins restless legs severity scale [J].
Allen, Richard P. ;
Earley, Christopher J. .
SLEEP MEDICINE, 2001, 2 (03) :239-242
[5]   Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology - A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health [J].
Allen, RP ;
Picchietti, D ;
Hening, WA ;
Trenkwalder, C ;
Walters, AS ;
Montplaisi, J .
SLEEP MEDICINE, 2003, 4 (02) :101-119
[6]   Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association [J].
Benetello, P ;
Furlanut, M ;
Fortunato, M ;
Pea, F ;
Baraldo, M .
PHARMACOLOGICAL RESEARCH, 1997, 35 (04) :313-315
[7]   ABNORMAL-RAT BRAIN MONOAMINE METABOLISM IN IRON-DEFICIENCY ANEMIA [J].
CHEN, Q ;
BEARD, JL ;
JONES, BC .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 1995, 6 (09) :486-493
[8]  
Cooper J.R., 1996, BIOCH BASIS NEUROPHA, V7th
[9]   Circadian time-dependent effects of fencamfamine on inhibition of dopamine uptake and release in rat striatal slices [J].
DeLucia, R ;
Planeta, CS ;
Ferreira, MP ;
Aizenstein, ML ;
Scavone, C .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1997, 30 (05) :637-640
[10]   Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome [J].
Earley, CJ ;
Connor, JR ;
Beard, JL ;
Malecki, EA ;
Epstein, DK ;
Allen, RP .
NEUROLOGY, 2000, 54 (08) :1698-1700